p27kip1 expression in non-small cell lung cancer is not an independent prognostic factor

Anticancer Research

Volumn 30, Issue 9, 2010, Pages 3699-3704

  Sion Vardy, Netta ^a,b   Freedman, Janna ^a   Lazarov, Irena ^a   Bolotin, Arkady ^a,b   Ariad, Samuel ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Lung cancer; p27kip1; p53; Pirh2; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PLATINUM; PROTEIN P53; PROTEIN PIRH2; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; CDKN1B PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; CANCER GROWTH; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR DIFFERENTIATION; DISEASE COURSE; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LUNG TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 77958614328     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Slingerland J and Pagano M: Regulation of the CDK inhibitor p27 and its deregulation in cancer. J Cell Physiol 183 :10-17, 2000.
3. kiP1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 15: 1211-1214, 1995.
4. kip1. Cancer Res 67: 10789-10795, 2007.
5. Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev 21: 1731-1746, 2007.
6. kip1 C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol Cell Biol 23: 216-228, 2003.
7. Zhu CQ, Shih W, Ling CH and Tsao MS: Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 59: 790-800, 2006.
8. kip1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16/INK4A, pRB, and p53. J Surg Oncol 81: 177-184, 2002.
9. Yoo J, Jung JH, Lee MA, Seo KJ, Shim BY, Kim SH, Cho DG, Ahn MI, Kim CH, Cho KD, Kang SJ and Kim HK: Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis. J Korean Med Sci 22: 318-325, 2007.
10. Garcia Lujan R, Conde Gallego E, Lopez Rios F, Martin De Nicolas JL, Sanchez Cespedes M, Garcia Quero C and Lopez Encuentra A: Prognostic value study of lung cancer molecular markers. Med Clin 132: 529-536, 2009.
11. Green FL, Page DL, Fleming ID, Fritz AG, Balch CM and Haller DG (eds). American Joint Committee on Cancer, AJCC Cancer Staging Handbook, 6th edition. New York: Springer-Verlag, UICC, 2006.
12. Detere S, Saccani G, Jotti L and Dowsett M: A 'quickscore' method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 48: 876-879, 1995.
13. Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M and Giordano A: Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 57: 3381-3385, 1997.
14. kip1 in human lung cancers: differential changes in small cell and non-small cell carcinomas. Cancer Res 58: 1042-1047, 1998.
15. kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras. Cancer Res 59: 684-688, 1998.
16. Ishihara S, Minato K, Hoshino H, Saito R, Hara F, Nakajima T and Mori M: The cyclin-dependent kinase inhibitor p27 as a prognostic factor in advanced non-small cell lung cancer: its immunohistochemical evaluation using biopsy specimens. Lung Cancer 26: 187-194, 1999.
17. kip1 protein and Ki-67 growth fraction in non-small cell lung cancers. Clin Cancer Res 6: 4073-4081, 2000.
18. kip1 expressions are potentially poor prognostic factors in lung adenocarcinoma patients. Lung Cancer 34: 59-65, 2001. (Pubitemid 32824124)
19. Takahashi S, Kamata Y, Tamo W, Koyanagi M, Hatanaka R, Yamada Y, Tsushima T, Takaya S and Fukuda I: Relationship between postoperative recurrence and expression of cyclin E, p27 and Ki-67 in non-small cell lung cancer without lymph node metastases. Int J Clin Oncol 7: 49-55, 2002.
20. Larrea MD, Wander SA and Slingerland JM: p27 as Jekyll and Hyde: Regulation of cell cycle and cell motility. Cell Cycle 8: 3455-3461, 2009.
21. Filipits M, Pirker R, Dunant A, Lantuejoul S, Schmid K, Huynh A, Haddad V, André F, Stahel R, Pignon JP, Soria JC, Popper HH, Le Chevalier T and Brambilla E: Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program. J Clin Oncol 25: 2735-2740, 2007.